US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

First Aid Antiseptic Ointment

Reason Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.

Zhejiang Jingwei Pharmaceutical Co., Ltd. D-0013-2025
Class II · Moderate risk Terminated

Pyridoxine HCL

Reason Lack of Assurance of Sterility

Empower Pharmacy NDC 72627-2424-1 D-0663-2024
Class II · Moderate risk Completed

Mupirocin Ointment

Reason Subpotent Drug

Glenmark Pharmaceuticals Inc., USA NDC 68462-180-22 D-0660-2024
Class II · Moderate risk Ongoing

TIRZEPATIDE 60 mg/3mL

Reason Lack of Assurance of Sterility

ProRx LLC NDC 84139-210-02 D-0656-2024
Class II · Moderate risk Ongoing

TIRZEPATIDE 20 mg/2mL

Reason Lack of Assurance of Sterility

ProRx LLC NDC 84139-210-01 D-0655-2024
Class II · Moderate risk Ongoing

SEMAGLUTIDE 10mg/4mL

Reason Lack of Assurance of Sterility

ProRx LLC NDC 84139-225-04 D-0653-2024
Class II · Moderate risk Ongoing

SEMAGLUTIDE 5mg/2mL

Reason Lack of Assurance of Sterility

ProRx LLC NDC 84139-225-01 D-0652-2024
Class II · Moderate risk Ongoing

Tirzepatide 2 mL

Reason Lack of Assurance of Sterility

ProRx LLC NDC 84139-210-01 D-0651-2024
Class II · Moderate risk Ongoing

Semaglutide

Reason Lack of Assurance of Sterility

ProRx LLC NDC 84139-225-01 D-0650-2024
Class II · Moderate risk Terminated

Cefixime for Oral Suspension USP

Reason Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-405-01 D-0648-2024
Class II · Moderate risk Ongoing

Lidocaine HCl Injection

Reason Lack of Assurance of Sterility

Fagron Compounding Services D-0636-2024
Class II · Moderate risk Ongoing

Timolol Maleate Ophthalmic Solution USP

Reason Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

FDC Limited NDC 64980-514-05 D-0642-2024
Class II · Moderate risk Ongoing

Ibuprofen 800mg

Reason Failed Impurities/Degradation Specifications: Product failed impurity specifications at the 18-month stability testing.

Direct Rx NDC 61919-0621-15 D-0041-2025
Class II · Moderate risk Ongoing

Ibuprofen Tablets

Reason Failed Impurities/Degradation Specifications - at 18-month Stability testing

Preferred Pharmaceuticals, Inc. NDC 68788-9110-03 D-0647-2024
Class II · Moderate risk Ongoing

Testosterone Gel

Reason Superpotent Drug

Teva Pharmaceuticals USA, Inc NDC 0591-2925-30 D-0637-2024
Class II · Moderate risk Ongoing

IBU Ibuprofen Tablets

Reason Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Dr. Reddy's Laboratories, Inc. NDC 55111-682-01 D-0646-2024
Class II · Moderate risk Ongoing

IBU Ibuprofen Tablets

Reason Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Dr. Reddy's Laboratories, Inc. NDC 55111-683-01 D-0645-2024
Class II · Moderate risk Ongoing

IBU Ibuprofen Tablets

Reason Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Dr. Reddy's Laboratories, Inc. NDC 55111-684-01 D-0644-2024
Class II · Moderate risk Completed

Hand-I-San

Reason CGMP Deviations: sterile water not used for production

Zeco LLC D-0640-2024
Class II · Moderate risk Completed

Rubbing Alcohol

Reason CGMP Deviations: sterile water not used for production

Zeco LLC D-0639-2024
Class II · Moderate risk Terminated

Empower Pharmacy

Reason Lack of Assurance of Sterility

Empower Clinic Services LLC D-0630-2024